10/24/2024
11:13 AM | BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
| Form SC 13G/A | |
10/22/2024
3:12 PM | OncoCyte (Filer)
| Form 424B3 | |
10/21/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
10/18/2024
3:55 PM | OncoCyte (Filer)
| Form S-3/A | |
10/16/2024
4:16 PM | OncoCyte (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/15/2024
3:15 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/09/2024
4:03 PM | OncoCyte (Subject)
SMITH PATRICK W (Filed by)
| Form SC 13G | |
10/04/2024
6:40 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
6:00 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
5:05 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:09 PM | OncoCyte (Filer)
| Form DEF 14A | |
08/09/2024
5:25 AM | OncoCyte (Filer)
| Form 424B5 | |
08/09/2024
5:37 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
08/08/2024
3:27 PM | OncoCyte (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/05/2024
3:01 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
8:00 PM | OncoCyte (Issuer)
SILVERMAN LOU (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:00 PM | Last Andrew J. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:00 PM | Arno Andrew (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
3:47 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
3:49 PM | James Andrea S. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
10:26 AM | OncoCyte (Filer)
| Form 424B3 | |
05/22/2024
11:15 PM | OncoCyte (Filer)
| Form EFFECT | |
05/17/2024
4:11 PM | OncoCyte (Filer)
| Form S-3/A | |
05/15/2024
3:21 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
4:31 PM | OncoCyte (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/29/2024
4:23 PM | OncoCyte (Filer)
| Form DEF 14A | |
04/22/2024
12:30 PM | BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
| Form SC 13G | |
04/15/2024
8:55 PM | OncoCyte (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
6:21 PM | BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
6:26 PM | BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
| Form SC 13D/A | |
04/15/2024
5:02 AM | Arno Andrew (Reporting)
OncoCyte (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
5:04 AM | OncoCyte (Issuer)
Riggs Josh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
5:04 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
4:28 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:47 PM | AWM Investment Company, Inc. (Filed by)
OncoCyte (Subject)
| Form SC 13G/A | |
01/23/2024
3:39 PM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:19 PM | OncoCyte (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
6:05 AM | OncoCyte (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
